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Abstract—This study attempts to ﬁnd a predictionmethod of death risk in patients with acute mediastinitis
(AM). There is no such tool described in available literature for this serious disease. The study comprised
37 consecutive cases of iatrogenic AM. General anamnesis and biochemical data were included. Factor
analysis was used to extract the risk characteristic for the patients. The most valuable results were obtained
for eight parameters, which were selected for further statistical analysis (all collected during a few hours
after admission). Three factors reached eigenvalue>1. Clinical explanations for these combined statistical
factors are as follows: Factor 1—proteinic status (serum total protein, albumin, and hemoglobin level),
Factor 2—inﬂammatory status (white blood cells, C-reactive protein, and procalcitonin), and Factor 3—
general risk (age and number of coexisting diseases). Threshold values of prediction factors were estimated
using statistical analysis (factor analysis, Statgraphics Centurion XVI). The ﬁnal prediction result for the
patients is constructed as simultaneous evaluation of all factor scores. High probability of death should be
predicted if factor 1 value decreases with simultaneous increase of factors 2 and 3. The diagnostic power of
the proposed method was revealed to be high [sensitivity0100 %, speciﬁcity069.2 %]: Factor 1
[SNC095.8 %, SPC076.9 %]; Factor 2 [SNC0100 %, SPC053.8 %]; and Factor 3 [SNC075 %,
SPC076.9 %]. The described method may turn out to be a valuable prognostic tool for patients with AM.
KEY WORDS: acute mediastinitis; prediction method; inﬂammatory status; proteinic status.
INTRODUCTION
Iatrogenic acute mediastinitis (IAM), deﬁned as an
infection of organs and tissues within mediastinal space
with accompanying sepsis following medical proce-
dures, is one of the most dangerous complications in
thoracic surgery. The death rate in acute mediastinitis
(AM) remains at a difﬁcult-to-accept level of 14 % to
47 % [1, 2]. Modern diagnostics, antibacterial therapy,
supporting treatment, and early qualiﬁcation for aggres-
sive surgery have not contributed to signiﬁcant improve-
ment of the treatment. The authors of this study made an
attempt to identify the most important risk factors and to
work out a prognostic scale called “AM risk calculator.”
Our fundamental assumption was to create a simple
and useful prognostic scale allowing early categoriza-
tion of patients requiring special management and
urgent surgery. The initial results of the application of
this scale in patients with AM of diverse etiology
(descending, posttraumatic, iatrogenic, and neoplastic)
seemed encouraging, and they were the subject of
earlier publications [3]. The scale sensitivity was
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90 %, and speciﬁcity was 64 %; however, the series
was heterogenic, considering the origin. With experi-
ence as our basis, we decided to check its diagnostic
value in a more homogeneous group of patients with
AM of only iatrogenic origin. To date, no method has
been available for evaluating the probability of
recovery if a patient has AM.
MATERIALS AND METHODS
Causes of IAM
In the years 1998–2011, at the Department of
Thoracic Surgery, General and Oncological Surgery of
the Medical University of Lodz, 37 consecutive patients,
in whom infection of mediastinum was the consequence
of complications following endoscopy and surgical
procedures mainly on the esophagus and the trachea,
were treated. The patients fulﬁlled the modiﬁed criteria
of mediastinitis diagnosis worked out by Esterra et al.
[6], which, in the original version, were related to
descending necrotizing mediastinitis: (1) clinical mani-
festation of severe infection; (2) demonstration of AM
etiological factors; (3) characteristic radiological picture
of mediastinitis; (4) isolation of the pathogen in
microbiological cultures from the mediastinal area; and
(5) intraoperative or postmortem documentation of
mediastinitis. IAM patients fulﬁlling all the above
criteria were included into the study group. Exponents
of sepsis in the form of fever, tachycardia, hyperventi-
lation, and leukocytosis were observed in all patients.
The study was approved by the Ethics Committee
of the Medical University in Lodz, Poland.
Surgical Management
All 37 patients with IAM underwent surgery.
Surgical strategy was determined to be individually
dependent on the etiology, delay from the diagnosis
establishment, local conditions, and the patient’s
general state. The surgery, ﬁrst of all, aimed at
controlling the infection source and at limiting local
inﬂammation by means of a wide cervical and/or
mediastinal drainage through various surgical ap-
proaches. Most procedures concerned the esophagus
and the trachea. Different surgeries were performed,
such as primary repair with ﬂapping or wrapping,
drainage only, esophageal exclusion or diversion, and
esophageal or tracheal resections.
Collected Data
The following clinical risk characteristics were evalu-
ated: age, gender, etiology, number of coexisting diseases,
delay in surgical treatment, isolated pathogens, type of
surgical procedure, the number and kind of postoperative
complications, and the number of transfused blood units. An
association between the selected clinical risk factors and
mortality was investigated. Two groups of patients were
compared to estimate the effect of the diagnosis-to-surgery
delay: surgery <24 h after IAM diagnosis [S<24 h] and
>24 h [S>24 h]. Then, the association between mortality
rate and selected biochemical risk factors was investigated
by analyzing the following parameters: hemoglobin level
[HGB], hematocrit, red blood cell count, white blood cell
count [WBC], platelet count, serum sodium [Na] and
potassium level [K], protein and albumin level, C-reactive
protein (CRP), and procalcitonin (PCT). In the case of
three inﬂammation markers: WBC, CRP, and PCT, their
levels were estimated in the preoperative period (pre) and
on day 3 postoperatively (post). The factors for which, in
statistical analysis, no association was found with the
prognosis were excluded from further studies.
Statistical Methods
Exploratory factor analysis (EFA) was used to
uncover the underlying structure of a relatively large set
of variables (i.e., eight in this study). The researcher’s
a priori assumption was that any indicator may be
associated with any factor. This is the most common form
of factor analysis. There is no prior theory, and one uses
factor loadings to intuit the factor structure of the data.
Statistical methods were used to select eight patient
features [age, coexisting diseases, HGB, WBC_pre,
CRP_pre, PCT_pre, proteins, and albumins], which
were included into the construction of prognostic factors
(Table 1). With a known statistical method (EFA) as
basis, three factors were extracted to cumulate prediction
power of collected patient features and to lower the
number of factors interpreted. Their equations were
calculated as follows:
Factor1 ¼ 0:712131HGBþ 0:854481Proteins
 0:131796Coex diseas
þ 0:00534419WBC pre 0:141942 Age
þ 0:908303Albumins 0:651832CRP pre
 0:560482PCT pre
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Factor2 ¼ 0:152337HGB 0:0461529Proteins
 0:0604516Coex diseas þ 0:914729WBC pre
þ 0:263779Age 0:0949298Albumins
þ 0:514794CRP preþ 0:371643PCT pre
Factor3 ¼ 0:243032HGB 0:0418942Proteins
þ 0:863627Coex diseasþ 0:108861WBC pre
þ 0:685527Age 0:167625Albumins
þ 0:0364827CRP preþ 0:141625PCT pre
where the values of the variables in the equation are
standardized by subtracting their means and dividing by
their standard deviations (Table 2).
The meaning of each factor was established by
analyzing the composition of the factor equations. It is a
typical next step in factor analysis. The factors were
called as follows: 1: Proteinic Status (because HGB,
protein level, and albumin level have the main contri-
bution in its value), 2: Inﬂammatory Status (because
HGB, protein level, and albumin level have the main
contribution in its value), and 3: General Risk (because
the number of coexisting diseases and patients’ age have
the main contribution in its value). These names give
intuitive interpretation of the value obtained for each
factor. Factor 1 has positive meaning—high level of
serum proteins is promising for a patient. Factors 2 and 3
have negative meaning—high level of inﬂammation
markers, high white blood cell count, older patients,
and more coexisting diseases are serious risk for IAM
survival. Thus, because it is the prediction of survival, it
will look for an intuitive “better” result:
Y In Factor 1, the value is higher than the threshold [intuitive
general “better” is when proteinic status is higher],
Y In Factors 2 and 3, the value is lower than the
threshold [intuitive “better” is when inﬂammatory
status and general risk are lower].
Thresholds for prediction were established
according to the previous study [3], i.e., authors
predicted recovery when proteinic status was higher
than −1.4 (i.e., the caesura in the distribution between
dead and recovered cases), inﬂammatory status was less
than 1.0 (the same caesura as in factor 1), and general
risk was less than 0.4 (the same caesura as in Factor 1)
(Fig. 1; Table 3). Prediction power and interpretation
reliability of the calculated factors are variable among
cases and that is why the authors looked for average
prediction way as below.
The ﬁnal prediction was established as cumulated
results of three factors: when two of three indicated
recovery, then recovery was the ﬁnal result of the
treatment, and when two of three factors indicated lethal
outcome, then death was the ﬁnal outcome of the
treatment.
Speciﬁcity (SPC) and sensitivity (SNC) coefﬁ-
cients of the prognostic method were calculated for
IAM to check the prediction power of the proposed
method. The method was designed for the prediction
of recovery; thus, the result of the test is positive [P]
as the test predicts the recovery and negative [N] as
the test does not predict the recovery, that is, “death.” The
result of the test is true [T] as the test predicts recovery
when the observed result was “recovery,” and the result of
the test is negative [N] as the test does not predict the
recovery (TP—patient recovered predicted as “recovery,”
TN—patient died predicted as “death,” FP—patient died
predicted as “recovery,” and FN—patient recovered
predicted as “death”)
With the above-mentioned deﬁnitions as bases,
sensitivity and speciﬁcity coefﬁcient equations are
proposed as follows:
Sensitivity coefﬁcient: SNC ¼ TPTPþFN 100%
Speciﬁcity coefﬁcient: SPC ¼ TNTNþFP 100%
The relation of the prediction factors to other collected
patient parameters was analyzed by simple regression.
Results were considered as signiﬁcant for p<0.05.
Table 1. Selected Eight Clinical Parameters Included to Prediction Schema
Case Age HGB WBC_pre CRP_pre PCT_pre Proteins Albumins Coex_Diseas
Avarage 57.68 12.40 16.91 209.45 2.12 58.38 30.75 3.41
Minimum 23.0 8.3 4.9 96.4 0.53 38.3 20.6 1
Maximum 83.0 19.5 36.3 459.2 10.3 73.6 35.1 6
Median 58.0 12.2 16.3 201.6 1.76 59.5 31.9 3.0
Standard deviation 11.18 2.18 4.88 78.86 1.74 7.29 4.22 1.57
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RESULTS
The age of the patients was from 23 to 83 years
(Table 1), mean 57.67 years (median 58.00). There
were 21 men, with mean age of 57.52 years (median
58.00), and 16 women, with mean age of 57.87 years
(median 61.50). The average time of hospitalization
was 22.13 (±10.48) days, with median of 19.00. The
time from the establishment of the diagnosis of IAM
to the introduction of surgical treatment ranged from 2
to 120 h (Table 1), with mean of 1.22 days (±1.12)
and median of (1.0).
Survival rate was 64.87 % in the published series.
Thirteen IAM patients died; the total death rate was
35.13 % (38.09 % in male subjects and 31.25 % in
female subjects).
The etiology of IAM was differentiated. There were
17 patients (45.95 %) after esophageal and tracheal
major surgical procedures (mortality, 47.06 %) and 20
(54.05 %) with injuries of these organs during endosco-
py or intubation (mortality, 25.00 %). Among the
isolated bacterial strains, there were 24 (64.86 %)
dominated aerobes, including 13 Gram negatives and
11 Gram positives. Anaerobes were detected in eight
patients (21.62 %) and mixed bacteria in ﬁve patients
(13.51 %). Streptococci (5), staphylococci (5), Klebsiella
(4), and Pseudomonas (3) were the most prevalent
bacterial strains.
Table 2. Standardized Parameters Used for Prediction Schema
Case Age_STND HGB_STND WBC_pre_STND CRP_pre_STND PCT_pre_STND Proteins_STND Albumins_STND Coex_Diseas_STND
1 −0.23926 −1.88008 −0.47335 1.443722 4.69243 −2.75297 −2.4039 −0.25721
2 0.029001 −0.8245 −0.33013 1.360031 0.172542 0.195317 0.392421 −0.89168
3 −0.95464 0.64414 0.201838 −0.4165 −0.17735 0.85354 0.961163 0.377248
4 0.297267 0.231085 −0.12553 −0.51668 −0.2175 0.154178 0.250235 −0.25721
5 −0.32869 0.64414 −0.63703 0.460987 −0.50429 −0.51776 0.036956 −1.52614
6 0.923219 −1.05397 −0.12553 0.518049 −0.67637 1.141512 0.890071 −0.89168
7 −0.32869 −0.50323 −0.24829 −0.27955 0.654358 −2.5747 0.273933 −0.89168
8 −3.10076 3.260149 −0.67795 −0.67518 −0.7452 0.867252 0.961163 −1.52614
9 0.386688 −0.68681 −0.71887 −0.09949 0.700245 −0.70974 −0.05783 −0.25721
10 0.833797 −0.54913 1.408989 0.44577 0.797755 −1.2994 −0.27111 −0.25721
11 2.264545 0.55235 −0.82117 −0.06145 −0.45267 1.45691 0.70049 0.377248
12 −0.41811 −1.25132 −0.20737 0.879442 0.31594 −1.20341 −2.3565 −0.89168
13 −0.59695 −0.45734 −1.02577 −1.03024 −0.85992 −0.40805 0.582002 −0.25721
14 −2.11712 1.011299 −0.86209 −0.67265 −0.91154 0.71641 0.724187 −1.52614
15 −0.77579 −0.36555 0.140457 1.004978 −0.16588 −0.86058 −1.4323 1.011709
16 0.029001 −0.22786 0.283678 −1.11139 −0.75094 0.291307 0.487211 −0.25721
17 0.47611 0.231085 0.140457 −0.25292 0.631414 0.113039 −0.10523 0.377248
18 −1.67001 −0.59502 −2.45799 −0.05384 −0.6649 −0.43548 −0.24741 −1.52614
19 0.297267 0.55235 −0.75979 −0.85017 −0.45841 0.743836 0.629397 −0.25721
20 0.744375 1.011299 0.365519 −0.18825 −0.36663 0.867252 0.961163 1.011709
21 0.029001 −1.00808 1.204387 0.060284 0.126655 0.044474 −0.27111 1.64617
22 0.47611 −0.27376 −0.35059 0.468595 0.407714 0.538141 0.108049 1.64617
23 −0.06042 −0.04428 −0.26875 −1.20269 −0.6649 0.030761 −0.10523 0.377248
24 −0.77579 0.231085 0.099537 −0.6346 −0.51577 2.087707 0.890071 −0.25721
25 −0.59695 0.64414 −0.10507 −1.43347 −0.70505 0.510715 0.961163 −0.89168
26 0.565532 0.690035 −0.04368 0.320234 −0.14867 −0.3532 −0.79246 1.011709
27 1.280906 1.332563 −0.53473 −1.32949 −0.76815 0.620419 0.582002 1.011709
28 0.833797 0.139296 0.345059 0.975813 0.86085 0.126752 −0.29481 1.011709
29 1.459749 0.64414 0.999785 0.559894 0.126655 −0.20236 0.463513 1.64617
30 0.923219 −1.55882 0.508741 2.104374 1.491799 −0.5589 −2.3565 1.64617
31 −0.06042 1.975092 −0.86209 −0.97444 −0.7452 1.155225 1.032256 −1.52614
32 0.118423 −1.42113 3.966513 −1.08603 −0.20603 −1.25826 −2.3802 1.011709
33 0.565532 0.139296 0.774723 −0.57881 −0.60754 0.277595 0.368723 −0.25721
34 −0.95464 −0.09018 1.368069 0.49142 0.998512 −0.79202 −0.08153 1.011709
35 0.386688 −0.54913 −0.10507 3.166997 0.040616 0.181604 −0.31851 −0.25721
36 −0.59695 −0.36555 0.40644 −0.78297 −0.67063 0.44215 0.368723 −0.89168
37 0.654954 −0.22786 −0.47335 −0.02975 −0.03395 0.510715 0.937466 0.377248
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The diagnosis-to-surgery delay was demonstrated
to decide about the prognosis. The group exposed to
surgery earlier [S<24] included 22 patients, and three of
them died (13.67 %); the group operated on later [S>24]
included 15 patients, and ten of them died (66.67 %).
Next, coefﬁcients of sensitivity and speciﬁcity
were calculated for each factor: proteinic status
[SNC095.80 %, SPC076.90 %], inﬂammatory status
[SNC0100 %, SPC053.80 %], and general risk
[SNC075 %, SPC076.9 %]. Later prevalence test
classiﬁcation [TP, TN, FP, and FN] was taken to establish
the whole prognostic power of the method among patients
with IAM—SNC0100 %, SPC069.20 %.
DISCUSSION
AM is one of the most severe complications, which
remains a great challenge for thoracic surgeons. High
death rate in patients with AM motivates to seek early
detection methods and monitoring, which may contrib-
ute to more effective management of this severe disease.
In the sequence of developing events, the patient’s
clinical picture and evaluation of laboratory tests, which
are the base for introducing further radiological and
endoscopic diagnostics and for qualiﬁcation for surgery,
provide the key data. Early aggressive surgical treat-
ment, selection of antibiotic therapy, and maintenance
treatment in the intensive care unit decide about the
success of the treatment [1, 2, 4]. Age, etiology,
coexisting diseases, delay in surgery, the kind of
procedure and time of its duration, the type of isolated
pathogen, blood transfusions, postoperative complica-
tions, and others are listed among clinical risk factors in
patients with AM [2–4, 9]. Biochemical parameter
monitoring provides important data concerning the
developing septic state. Deviation from their values
often anticipates clinical symptoms. Systematic analysis
of biochemical parameters revealed signiﬁcant impor-
tance of detailed examination of patients in AM [5].
Our prognostic method consists of three factors, the
results of which decide about the prognosis. Two
parameters were taken into account to evaluate the
general risk: age and the number of coexisting diseases.
They are often listed among the factors related to poor
prognosis in critically ill patients with sepsis [6]. They
had been used in already existing prognostic scales for
the determination of long-term survival, such as
Charlson comorbidity index (CCI), Davies (Stokes)
score, and index of coexistent diseases (ICED) [7–9].
CCI is used most frequently and consists of 19
coexisting diseases, which are assigned with a score.
The age scores are counted according to the following
manner: one score for each decade over 40 years of age.
The scores are summed up and give a total score, which
enables to predict mortality [7]. In our method, Factor 3,
Fig. 1. Algorithm of prediction the outcome for patient affected by iatrogenic acute mediatinitis.
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responsible for general condition, demonstrated a rela-
tively high value in predicting the prognosis (SNC0
75 %, SPC076.9 %). Many authors emphasize the
importance of early qualiﬁcation for surgery in regard to
the prognosis [2, 10]. In our patients, we observed nearly
ﬁve times lower death rate if the surgery was performed
within the ﬁrst 24 h. However, this parameter showed no
statistical signiﬁcance in relation to the three factors of
our scale. We suspect that surgical delay is not a
parameter to be measured objectively. Diagnosis of
IAM in patients after major thoracic surgeries receiv-
ing antibiotics and strong analgesics is, as a rule,
delayed for a few hours. Wang et al. think that, in the
era of advanced intensive care capabilities, delay in
primary repair of the esophagus does not have to be
associated with worse result in some patients [11].
Because of that, we have not included this parameter
into the suggested scale.
There are several prognostic scales using the
evaluation of protein metabolism and the severity of
the infection based on laboratory parameters. Among
biochemical markers, protein and albumin levels are
most frequently used in nutritional status assessment
[12, 13]. In 1988, Buzby et al. ﬁrst described the NRI to
score the severity of postoperative complications [14]. It
combines two nutritional indicators (albumin and weight
loss), which are strictly correlated with higher morbidity
and mortality risk. GNRI is a similar but more objective
scale, devoid of the need for calculating the ideal body
weight [15]. With the conducted factor analysis as our
basis, we have demonstrated that there is also a need for
inclusion of the level of hemoglobin (among other blood
proteins) into the proteinic status. The presence of
preoperative anemia and high intraoperative blood loss
is a known factor affecting poor prognosis, particularly
in combination with other diseases [16, 17].
We are convinced that limitation to the assessment
of the nutritional status itself does not provide satisfac-
tory information for the prediction of the prognosis. It
seems that, in the case of an infectious disease, the scales
analyzing nutritional status in combination with bio-
chemical parameters of inﬂammation have greater
diagnostic value.
Prognostic inﬂammatory and nutritional index
(PINI), worked out by Ingenbleek and Carpentier, is
one of the most frequently used prognostic scales in
critically ill patients, an index, which takes into
account the above parameters [18]. The scale is based
on the evaluation of four parameters: two markers of
nutritional (albumin and prealbumin) and two markers
of inﬂammatory CRP and AAG states. PINI has been
found to be a reliable indicator of both nutritional
status and prognosis in trauma, burns, infection [19],
and lately, in cancer [20]. PINI is the closest scale to
that proposed by us, comprising two of three analyzed
groups of risk factors.
It is commonly accepted that CRP and PCT are
markers of high sensitivity and speciﬁcity in sepsis,
septic complications, and cancers [21–23]. The statistical
analyses performed earlier demonstrated higher mean
number of WBC in the group of patients with AM who
died [5]. Therefore, inclusion of this parameter into the
group of factors determining “inﬂammatory status”
seems to be appropriate, not purely from the mathemat-
ical point of view. It should be reminded that the WBC
value is one of the criteria of SIRS and sepsis diagnosis
[24]. It should be emphasized that the patients’ nutri-
tional status can affect CRP and PCT values. According
to Ballou and Kushner, the level of CRP is
prognostically more important in the monitoring of the
patient’s condition in malnutrition than other acute phase
proteins, and it increases signiﬁcantly [21]. Other
authors also conﬁrm that nutritional status can affect
inﬂammatory response in patients with advanced carci-
noma and the results of PINI prognostic scale [25, 26].
Therefore, in these cases, the concentration of CRP
alone may be a sufﬁcient indicator of the inﬂammatory
response [26].
Wunder et al. presented an interesting attempt of
working out an independent indicator of early prediction
of death in sepsis [27]. The authors, analyzing 33
patients with sepsis of different etiology, noticed that
the deviations of PCT values and Acute Physiology and
Chronic Health Evaluation (APACHE II) were correlat-
ed with poor prognosis. Novotny et al. [28] carried out
similar studies on a larger group of 160 patients with
sepsis resulting from peritonitis or mediastinitis after an
anastomotic leak or perforation of a hollow organ. It
should be emphasized that the clinical material presented
in this study was greatly similar to our material. The
authors combined both indicators and calculated a
prognosis score using binary logistic regression analysis,
which allowed the identiﬁcation of groups with high
and low risk of death. In a multivariate analysis, both
PCT values and the APACHE III score were
identiﬁed as independent, early predictive indicators
of sepsis lethality.
We think that the use of three markers for the
assessment of inﬂammatory status allows more precise
and complex evaluation of this status and prognosis,
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eliminating errors resulting from heterogeneity of the
investigated group and known deviations in the behavior
of the selected markers in some severe morbid states.
The ﬁnal diagnostic value of AM risk calculator
turned out to be high in relation to other discussed
scales. We think that the construction of our prognostic
method based on the evaluation of three groups of risk
factors determining inﬂammatory, proteinic, and general
status will be less sensitive to difﬁcult-to-foresee de-
viations of the values of biochemical markers associated
with the impact of factors such as malnutrition,
bacteriological etiology, comorbidities, and surgical
complications. Thus, the described method is a promis-
ing prognostic tool for patients with IAM. AM risk
calculator can be prepared in a user-friendly electronic
version in which, after introduction of the required data,
the predicted prognosis will be obtained automatically.
The categorization of the patients most at risk will
enable early intensiﬁcation of the medical management.
CONCLUSIONS
We do hope that the proposed AM risk calculator will
be introduced into the clinical practice, which can contribute
to the modiﬁcation of the treatment of patients with AM. It
is based on mathematical assessment of our own material
and devoid of subjective interpretation. Inclusion into the
assessment of two simple clinical data and six biochemical
tests, which can be obtained within the ﬁrst 1–2 h after the
patient’s admission to hospital (duration of laboratory
investigations); low costs; and simple interpretation of the
results are the most important advantages.
Open Access This article is distributed under the
terms of the Creative Commons Attribution License
which permits any use, distribution, and reproduction in
any medium, provided the original author(s) and the
source are credited.
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